|
US10022A
(en)
|
|
1853-09-13 |
|
Lard-lamp |
|
US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
|
US4452818A
(en)
|
1982-03-19 |
1984-06-05 |
Haidt Sterling J |
Extraocular method of treating the eye with liquid perfluorocarbons
|
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
|
JPS6452722A
(en)
|
1987-05-01 |
1989-02-28 |
Anjierini Pharmaceut Inc |
Ophthalmic composition
|
|
US6458376B1
(en)
|
1990-09-27 |
2002-10-01 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery suspensions
|
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
|
GB9114374D0
(en)
|
1991-07-03 |
1991-08-21 |
Smithkline Beecham Plc |
Novel process
|
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
|
DE4405627A1
(de)
|
1994-02-22 |
1995-08-24 |
Hoechst Ag |
Fluorkohlenwasserstoffe enthaltende Ölemulsionen
|
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
|
US5696164A
(en)
|
1994-12-22 |
1997-12-09 |
Johnson & Johnson Consumer Products, Inc. |
Antifungal treatment of nails
|
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
|
US5667809A
(en)
*
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
|
DE19536504C2
(de)
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
US5863560A
(en)
|
1996-09-11 |
1999-01-26 |
Virotex Corporation |
Compositions and methods for topical application of therapeutic agents
|
|
IN184589B
(cg-RX-API-DMAC7.html)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
|
US5981607A
(en)
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
|
US6224887B1
(en)
|
1998-02-09 |
2001-05-01 |
Macrochem Corporation |
Antifungal nail lacquer and method using same
|
|
DE19861012A1
(de)
|
1998-03-18 |
1999-09-30 |
Pharm Pur Gmbh |
Behandlungsmittel für die Ophthalmologie
|
|
ES2211151T3
(es)
|
1998-08-19 |
2004-07-01 |
Skyepharma Canada Inc. |
Dispersiones acuosas inyectables de propofol.
|
|
US6140374A
(en)
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
|
US6159977A
(en)
|
1998-11-16 |
2000-12-12 |
Astan, Inc. |
Therapeutic anti-fungal nail preparation
|
|
ATE322889T1
(de)
|
1999-02-08 |
2006-04-15 |
Alza Corp |
Stabile nicht wässerige einphasige visköse vehikeln und formulierungen die diese vehikeln verwenden
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
AU3898700A
(en)
|
1999-03-15 |
2000-10-04 |
John Claude Krusz |
Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
|
|
US6177477B1
(en)
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
|
US6239113B1
(en)
*
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
DE19926890C1
(de)
|
1999-06-12 |
2000-07-27 |
Pharm Pur Gmbh |
Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
|
|
DE19938668B4
(de)
|
1999-08-14 |
2006-01-26 |
Bausch & Lomb Inc. |
Tränenersatzmittel
|
|
JP2001158734A
(ja)
|
1999-12-02 |
2001-06-12 |
Lion Corp |
眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
|
|
US20030018044A1
(en)
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
|
DE10024413A1
(de)
|
2000-05-19 |
2001-12-06 |
Mika Pharma Gmbh |
Pharmazeutische und/oder kosmetische Zubereitung
|
|
US6399087B1
(en)
|
2000-12-20 |
2002-06-04 |
Amphastar Pharmaceuticals, Inc. |
Propofol formulation with enhanced microbial inhibition
|
|
US20030027833A1
(en)
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
JP4654128B2
(ja)
|
2003-06-27 |
2011-03-16 |
湧永製薬株式会社 |
硬カプセル剤
|
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
|
EP1684724A4
(en)
|
2003-11-19 |
2008-04-02 |
Barnes Jewish Hospital |
IMPROVED DRUG DELIVERY
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
US20080019926A1
(en)
*
|
2004-04-19 |
2008-01-24 |
Marie-Pierre Krafft |
Lung Surfactant Supplements
|
|
US20050288197A1
(en)
|
2004-06-08 |
2005-12-29 |
Ocularis Pharma, Inc. |
Silicone polymer topical eye compositions and methods of use
|
|
US7063241B2
(en)
|
2004-06-10 |
2006-06-20 |
Allergan, Inc. |
Dispensing tip
|
|
US20060009522A1
(en)
|
2004-07-01 |
2006-01-12 |
Reza Dana |
Compositions and methods for treating eye disorders and conditions
|
|
US7740875B2
(en)
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
EP1688161A1
(en)
|
2004-11-02 |
2006-08-09 |
Switch Biotech Aktiengesellschaft |
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
|
|
GB0511499D0
(en)
|
2005-06-06 |
2005-07-13 |
Medpharm Ltd |
Topical ungual formulations
|
|
DE602006004887D1
(de)
|
2005-08-05 |
2009-03-05 |
Bharat Serums & Vaccines Ltd |
Intravenöse propofol-emulsionszusammensetzungen mit konservierendem effekt
|
|
FR2892023B1
(fr)
|
2005-10-14 |
2009-09-25 |
Galderma Sa |
Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
|
|
DE102005055811A1
(de)
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
JP5694664B2
(ja)
|
2006-09-29 |
2015-04-01 |
サーモディクス，インコーポレイティド |
生分解性眼用インプラント及び眼の病気を治療する方法
|
|
US9000048B2
(en)
|
2006-11-28 |
2015-04-07 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
|
EP2089282B1
(en)
|
2006-12-07 |
2014-01-08 |
Sun Pharma Advanced Research Company Ltd |
Metered drop bottle for dispensing microliter amounts of a liquid in the form of a drop
|
|
ITMI20070890A1
(it)
|
2007-05-04 |
2008-11-05 |
Sifi Spa |
Composizioni oftalmiche per il trattamento della ipertensione oculare e del glaucoma
|
|
FR2918891B1
(fr)
|
2007-07-20 |
2009-09-25 |
Thea Sa Lab |
Solution ophtalmique a base de prostaglandines sans conservateur
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
DE102007055046A1
(de)
*
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
|
ES2377152T3
(es)
|
2008-04-18 |
2012-03-22 |
Novaliq Gmbh |
Uso inhalativo e instilativo de alcanos semifluorados como vehículos de principios activos en la región intrapulmonar
|
|
US20100006600A1
(en)
|
2008-07-14 |
2010-01-14 |
Dascanio Gustavo A |
Fluid dispenser including hydrophobic ring
|
|
EP2367527A2
(en)
|
2008-11-26 |
2011-09-28 |
SurModics, Inc. |
Implantable ocular drug delivery device and methods
|
|
US8501800B2
(en)
*
|
2009-03-05 |
2013-08-06 |
Insite Vision Incorporated |
Controlled-release ophthalmic vehicles
|
|
IT1393419B1
(it)
|
2009-03-19 |
2012-04-20 |
Medivis S R L |
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
|
|
WO2010146536A1
(en)
|
2009-06-18 |
2010-12-23 |
Koninklijke Philips Electronics N.V. |
Suspension of particles with drug
|
|
JP5736635B2
(ja)
|
2009-06-25 |
2015-06-17 |
ライオン株式会社 |
ドライアイ治療剤
|
|
JP5549669B2
(ja)
|
2009-06-25 |
2014-07-16 |
ライオン株式会社 |
眼科用組成物、ドライアイ治療剤及びビタミンａの安定化方法
|
|
JP2013500239A
(ja)
|
2009-07-24 |
2013-01-07 |
ミーカ ファルマ ゲゼルシャフト フュア ディー エントヴィックルング ウント フェアマルクトゥング ファルマツォイティッシャー プロドゥクテ ミット ベシュレンクテル ハフツング |
活性剤を含む発泡可能な液体組成物およびその製造または開発方法
|
|
JP2011024841A
(ja)
|
2009-07-28 |
2011-02-10 |
健太 ▲浜崎▼ |
点眼補助具
|
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
|
ES2564502T3
(es)
|
2010-03-17 |
2016-03-23 |
Novaliq Gmbh |
Composición farmacéutica para el tratamiento de la presión intraocular aumentada
|
|
DE102010022567A1
(de)
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
TR201901309T4
(tr)
|
2011-01-04 |
2019-02-21 |
Novaliq Gmbh |
Semiflorlanmış alkanları içeren o/w emülsiyonları.
|
|
PL2714010T3
(pl)
|
2011-05-25 |
2017-08-31 |
Novaliq Gmbh |
Kompozycja farmaceutyczna do miejscowego stosowania oparta na semifluorowanych alkanach
|
|
CN103561724B
(zh)
|
2011-05-25 |
2016-06-29 |
诺瓦利克有限责任公司 |
给药给甲的药物组合物
|
|
MX361681B
(es)
|
2012-01-23 |
2018-12-13 |
Novaliq Gmbh |
Composiciones de proteína estabilizadas basadas en alcanos semifluorados.
|
|
WO2013126602A1
(en)
|
2012-02-21 |
2013-08-29 |
Massachusetts Eye & Ear Infirmary |
Inflammatory eye disorders
|
|
US9878000B2
(en)
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
|
WO2014041071A1
(en)
|
2012-09-12 |
2014-03-20 |
Novaliq Gmbh |
Semifluorinated alkane compositions
|
|
CN113679699B
(zh)
|
2012-09-12 |
2022-10-28 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
MX2015007931A
(es)
|
2012-12-18 |
2015-10-05 |
Novartis Ag |
Composiciones y metodos que utilizan una etiqueta de peptido que se une a hialuronano.
|
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
|
DK3024484T3
(en)
|
2013-07-23 |
2018-10-08 |
Novaliq Gmbh |
STABILIZED ANTIBODY COMPOSITIONS
|
|
WO2015153469A1
(en)
|
2014-03-31 |
2015-10-08 |
Amcor Limited |
Controlled release container
|
|
EP2944324A1
(de)
|
2014-05-13 |
2015-11-18 |
LTS LOHMANN Therapie-Systeme AG |
Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
|
|
CN106572941B
(zh)
|
2014-08-13 |
2020-06-23 |
佛罗里达大学研究基金会股份有限公司 |
从眼药水中去除防腐剂
|
|
CN110403923B
(zh)
|
2015-09-30 |
2021-09-21 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
KR102584063B1
(ko)
|
2015-09-30 |
2023-09-27 |
노바리크 게엠베하 |
부분불소화 화합물
|
|
AU2017275492A1
(en)
|
2016-06-01 |
2018-12-20 |
Harold Richard Hellstrom |
Treatment of dry eye disease with parasympathetic and anti-sympathetic agents
|
|
KR102257916B1
(ko)
|
2016-06-23 |
2021-05-28 |
노바리크 게엠베하 |
드롭 디스펜서를 포함하는 키트
|
|
EP3518921B1
(en)
|
2016-09-28 |
2021-08-11 |
Novaliq GmbH |
Compositions comprising a cannabinoid receptor binding ligand
|
|
CA3045733C
(en)
|
2016-12-22 |
2024-01-16 |
Novaliq Gmbh |
Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseases
|
|
EP3399962B1
(en)
|
2016-12-23 |
2020-06-10 |
Novaliq GmbH |
Ophthalmic composition for treatment of dry eye disease
|